جاهز للتشغيل
جاهز للتشغيل
Patients and doctors report that a new pancreatic cancer drug is significantly extending survival rates. The medication is considered a breakthrough in treatment, offering hope for improved outcomes in a previously challenging cancer type.
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading